-+ 0.00%
-+ 0.00%
-+ 0.00%

Minerva Neurosciences Q3 EPS $(0.19) Beats $(0.21) Estimate

Benzinga·11/06/2026 14:03:19
Listen to the news
Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 47.22 percent increase over losses of $(0.36) per share from the same period last year.